Free Trial

This company has been marked as potentially delisted and may not be actively trading.

OncoCyte (OCX) News Today

OncoCyte logo

OCX Latest News

Oncocyte Reports Q1 2025 Results and Business Progress
OncoCyte Q1 2025 Earnings Preview
OncoCyte files to sell 10.61M shares of common stock for holders
OncoCyte initiated with a Buy at Lake Street
OncoCyte (NASDAQ:OCX) Announces Earnings Results
Oncocyte corp CFO buys $200,000 in stock
Oncocyte Prices $29.1 Million Equity Offering
Get OncoCyte News Delivered to You Automatically

Sign up to receive the latest news and ratings for OCX and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OCX Media Mentions By Week

OCX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OCX
News Sentiment

0.00

1.09

Average
Medical
News Sentiment

OCX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OCX Articles
This Week

0

2

OCX Articles
Average Week

Get the Latest News and Ratings for OCX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for OncoCyte and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:OCX) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners